Dynamic Technology Lab Private LTD Reata Pharmaceuticals Inc Transaction History

Dynamic Technology Lab Private LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $199,534 - $375,117	10,280 New	10,280 $259,000
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $378,684 - $621,720	-15,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $342,917 - $1.49 Million	13,390 Added 579.65%	15,700 $414,000
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $231,000 - $330,376	2,310 New	2,310 $233,000
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $447,156 - $864,319	-5,713 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $538,450 - $758,743	5,713 New	5,713 $570,000
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $151,425 - $264,447	-1,619 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $204,479 - $285,850	1,619 New	1,619 $253,000
Q1 2020 May 13, 2020	SELL	$124.16 - $247.74 $213,803 - $426,608	-1,722 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $95,300 - $278,501	-1,278 Reduced 42.6%	1,722 $352,000
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $213,780 - $287,250	3,000 New	3,000 $241,000
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $274,429 - $333,149	-3,531 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$51.9 - $101.79 $183,258 - $359,420	3,531 New	3,531 $302,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.